Actively Recruiting
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
Led by Hackensack Meridian Health · Updated on 2026-05-26
10000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Early diagnosis of cancer improves treatment outcomes, survival rates, and reduces care costs. Monitoring cancer in people at risk is crucial for early detection. The HMH Hennessey Institute for Cancer prevention and Applied Molecular Science (HICAP) offers clinical cancer screening and risk assessment, along with research on cancer risk and prevention. This study, the CanScan registry, will collect data over time from participants through questionnaires and routine assessments to better understand cancer risk, screening, and diagnostics. Participants will provide data via questionnaires and consent to share information from standard non-research assessments. The registry will gather information on genetic, environmental, and lifestyle factors linked to cancer risk. This observational study does not involve experimental treatments but follows participants to observe cancer-related outcomes and risk factors over time. Participants will be followed for up to 10 years, during which researchers will monitor rates of inherited genetic variants linked to cancer, new cancer cases, genetic risk scores, lifestyle influences, and the impact of early detection on cancer outcomes. Involvement includes completing questionnaires and allowing access to routine clinical data. This long-term observation aims to improve understanding and prevention of cancer in at-risk populations.
CONDITIONS
Brief Title
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years and older
- Ability to provide own consent
- Must meet at least one increased cancer risk criterion including:
- Family or personal history suggesting hereditary cancer risk
- Personal factors like benign breast disease, polyps, or tobacco use
- Family member of a participant
- Any participant in the HICAP program regardless of cancer risk
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants are observed over an extended period to assess genetic and environmental factors related to cancer risk and outcomes.
Periodic visits over 10 years
Trial Site Locations
Total: 1 location
1
Hennessy Institute for Cancer Prevention and Applied Molecular Medicine
Totowa, New Jersey, United States, 07462
Actively Recruiting
Research Team
L
Lee Ifhar, MSc, CCRP
R
Renata Castro, MS
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here